A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501
Last updated 2023-06-09
Summary
The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).
Conditions
- Carcinoma, Non-Small-Cell Lung
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-09
- Primary Completion
- 2023-01-04
- Completion
- 2023-01-04
Countries
- United States
Study Locations
More Related Trials
-
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
NCT05778045 ·Status: NOT_YET_RECRUITING
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
NCT00483015 ·Status: COMPLETED
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma
NCT05984017 ·Status: RECRUITING
-
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
NCT00721981 ·Status: TERMINATED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
NCT04137718 ·Status: UNKNOWN
-
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
NCT07215026 ·Status: COMPLETED
-
A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes
NCT03710629 ·Status: UNKNOWN
-
Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC
NCT05725915 ·Status: UNKNOWN
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
NCT05761093 ·Status: RECRUITING
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027 ·Status: COMPLETED ·Phase: NA
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung Cancer
NCT05959265 ·Status: UNKNOWN ·Phase: NA
-
Prospective Observational Study on ES-SCLC
NCT07173946 ·Status: NOT_YET_RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Determining Clinical Trial Experiences of Lung Cancer Patients
NCT05760170 ·Status: NOT_YET_RECRUITING